• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Opinions
    • Top 30
    • Research
    • Supply Chain
    • Device Sectors
    • Directory
    • Events
    • Resources
    • Microsites
    • More
  • Magazine
  • News
  • Opinions
  • Top 30
  • Research
  • Supply Chain
  • Device Sectors
  • Directory
  • Events
  • Resources
  • Microsites
  • Current / Back Issues
    Features
    Editorial
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Reprints
    Subscribe Now
    Advertise Now
    Top Features
    Adding Fabrication Capabilities: Additive Manufacturing for Production Parts

    Delivering the Goods: The Evolving World of Combination Products

    Anxious Undertones: The 2019 Year in Review

    From Art to Science: The Changing Face of Extrusion

    Exact Science: A Micromolding Roundtable
    OEM News
    Supplier News
    Service / Press Releases
    Online Exclusives
    Press Releases
    People in the News
    Product & Service Releases
    Supplier News
    Technical Features
    International News
    Videos
    Product & Service Releases
    Live From Shows
    Top News
    FDA OKs World's First Single-Use Duodenoscope

    Dr. Stephen Hahn Confirmed as New FDA Leader

    FDA OKs First Test to Help Screen for Newborn Duchenne Muscular Dystrophy

    MedStar Health and Cleveland Clinic Innovations Awarded Grant

    3M to Sell Drug Delivery Business for $650M
    From the Editor
    Blogs
    Guest Opinions
    Top Opinions
    Adding Fabrication Capabilities: Additive Manufacturing for Production Parts

    Delivering the Goods: The Evolving World of Combination Products

    Anxious Undertones: The 2019 Year in Review

    From Art to Science: The Changing Face of Extrusion

    Exact Science: A Micromolding Roundtable
    Top 30 Medical Device Companies
    Market Data
    White Papers
    Top Research
    From Genome Sequencing to the World’s First Portable MRI

    An Update on Digital Health

    ‘If You’re Reading This, You Need to Be at This Meeting’

    Five Steps for Succeeding Globally in Medtech

    Unlocking Market Doors with Real-World Evidence
    3D/Additive Manufacturing
    Contract Manufacturing
    Electronics
    Machining & Laser Processing
    Materials
    Molding
    Packaging & Sterilization
    R&D & Design
    Software & IT
    Testing
    Tubing & Extrusion
    Cardiovascular
    Diagnostics
    Digital Health
    Neurological
    Patient Monitoring
    Surgical
    All Companies
    Categories
    Company Capabilities
    Add New Company
    Outsourcing Directory
    DELMIAWORKS (IQMS)

    Nelson Laboratories LLC

    Zeus

    Glenbrook Technologies Inc.

    Eurofins Medical Device Testing
    MPO Summit
    Industry Events
    Webinars
    Live From Show Event
    Industry Associations
    Videos
    Career Central
    eBook
    Slideshows
    Top Resources
    EU's MDR: Irresistible Force Meets Immovable Object

    Ladies First: An Examination of the Women's Health Device Industry

    Localizing Medical Devices

    Sounding Board: Looking Back at 2019 and Gazing at 2020

    Understanding Key Processes for Mixing APIs with Silicone
    Companies
    News Releases
    Product Releases
    Press Releases
    Product Spec Sheets
    Service Releases
    Case Studies
    White Papers
    Brochures
    Videos
    Outsourcing Directory
    Pulse Systems

    Zeus

    Fusion Biotec Inc.

    Command Medical Products Inc.

    DELMIAWORKS (IQMS)
    • Magazine
      • Current/Back Issues
      • Features
      • Editorial
      • Columns
      • Digital Editions
      • Subscribe Now
      • Advertise Now
    • News
    • Directory
      • All Companies
      • ALL CATEGORIES
      • Industry Associations
      • Company Capabilities
      • Add Your Company
    • Supply Chain
      • 3D/Additive Manufacturing
      • Contract Manufacturing
      • Electronics
      • Machining & Laser Processing
      • Materials
      • Molding
      • Packaging & Sterilization
      • R&D & Design
      • Software & IT
      • Testing
      • Tubing & Extrusion
    • Device Sectors
      • Cardiovascular
      • Diagnostics
      • Digital Health
      • Neurological
      • Patient Monitoring
      • Surgical
    • Top 30 Company Report
    • Expert Insights
    • Slideshows
    • Videos
    • Podcasts
    • Resources
    • eBook
    • Infographics
    • Whitepapers
    • Research
      • White Papers
      • Case Studies
      • Product Spec Sheets
      • Market Data
    • MPO Summit
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Microsite
      • Companies
      • Product Releases
      • Product Spec Sheets
      • Services
      • White Papers / Tech Papers
      • Press Releases
      • Videos
      • Literature / Brochures
      • Case Studies
    • About Us
      • About Us
      • Contact Us
      • Advertise with Us
      • eNewsletter Archive
      • Privacy Policy
      • Terms of Use
    Columns

    First Come, First Served: Class I Manufacturers Stand in Line for EU MDR Certification

    The days remaining to attain EU Medical Device Regulation (MDR) compliance are numbered.

    First Come, First Served:  Class I Manufacturers Stand in Line for EU MDR Certification
    Related CONTENT
    • Sum and Substance: Material Considerations for Changing Design Needs
    • Converging Goals: How a Focus on the Patient Drives Stronger Healthcare Partnerships
    • Laboratory Testing with Nelson Labs at BIOMEDevice Boston
    • MedTech Innovator Selects 50 Best-in-Class Startups for 2019 Showcase and Accelerator
    • Toughened Epoxy Polysulfide Hybrid Offers Advanced Chemical Resistance
    Peter Rose, Managing Director—Europe, Maetrics09.06.19
    The days remaining to attain EU Medical Device Regulation (MDR) compliance are numbered, while the notified bodies central to manufacturers achieving said compliance are few and far between. With a significant shortage of notified bodies in the European regulatory arena, the risk is real for manufacturers who wait too long to get their compliance matters in order. Any manufacturer unable to receive CE certification by the upcoming deadline on May 26, 2020, or by the end of any extended transition period according to current Medical Device Directive (MDD) certificate expiry date, will have to deal with the regrettable consequence of having their products removed from the EU market, and any associated cash-flow repercussions and reputational damages to their business.

    Particularly vulnerable to being left behind are Class I manufacturers who cannot benefit from any extended transition period, some of whom may not even be aware of their entanglement with the new regulation’s requirements, given their exemption from such obligations under the previous directive. EU MDR compliance does not solely apply to manufacturers of high-risk products as it is commonly assumed but to all manufacturers regardless of past classification, including Class I. With such misconceptions floating around, it is important to set things straight for all manufacturers. This article will aim to clarify matters, highlighting the principle changes and challenges that moving away from the previous MDD and embarking on the road toward EU MDR compliance entails, with a particular focus on the urgency for manufacturers to promptly join the queue for notified body assistance now, as they are likely to have to wait their turn for a full review of all technical documentation.

    As a first point of action, manufacturers are advised to consult Annex VIII of the EU MDR, which will reveal any changes of classification, and in turn, any potential new conformity assessment routes they are to follow for their products. Indeed, the EU MDR contains not only four new classification rules but also some significant changes to pre-existing ones, some of which will altogether alter the category under which a product falls. Manufacturers must therefore swiftly become acquainted with these modifications, in order to first determine if their products have been up-classified to another sub-section of Class I, Class IIa, IIb, and Class III, or alternatively, if their product grouping remains untouched. If a manufacturer’s device remains a Class I device under the EU MDR, they may continue to self-certify as long as their technical documentation is up to date in time for the MDR deadline, for which they will need to self-declare the conformity of their devices with the requirements of the MDR and register relevant details on the EUDAMED database.

    For Class I manufacturers that have found their products to be up-classified, however, this reshuffling may result in their devices being subject to regulation by a notified body for the first time. One particular illustration of this is Class I reusable surgical instruments, which as per Article 52 (7c) of the EU MDR, will now belong to a new category of their own, known as Class Ir. Products that fall under the new Class Ir group will require inspection of cleaning, repackaging, and reprocessing aspects from a notified body—something unprecedented given no such reviews were required for these products under the MDD. Other examples of this restructuring include spinal products (MDR Annex VII, rule 8), standalone software (MDR Annex VII, rule 11), and products without an intended medical purpose (Annex XVI). Similarly, given that grandfathering of products is not allowed under the EU MDR, medical devices that have already been circulating on the market for many years, but entered the market prior to an ongoing standard, directive, or regulation, will also need to receive new CE certification.

    Having established the classification of their products under the new regulation, manufacturers are ready to begin taking the first steps toward achieving EU MDR compliance. This stage of the process will be most effective if manufacturers are able to establish a timeline for the implementation of these next stages of the operation. While some medical device manufacturers may have already initiated implementation efforts, others will require more time and guidance. Each business must therefore try to assess the timeframe and resources required to bring their compliance plans to fruition. The need for speed and efficiency is particularly crucial for Class I manufacturers; while other Classes of manufacturers who have been recertified under the MDD before 2020 can benefit from up to a four-year extension for the completion of compliance, Class I manufacturers have not been granted any additional time allowance and must achieve compliance by May 26, 2020.

    Adding to the urgency of the situation is the untimely shortage of notified bodies operating throughout Europe, with multiple organizations withdrawing from medical device regulation, and the resulting issue of capacity across the medical device industry. With only three notified bodies having presently been designated under the EU MDR (the announcement of Germany-based Dekra Certification GmbH came in August), the regulatory expertise vital in assisting manufacturers will be hard to come by. It is estimated the number of available notified bodies will significantly rise before the end of 2019, suggesting the work would be divided up between approximately 16 to 20 notified bodies. While this is an improvement, the vast number of technical documents being submitted for review means these organizations will nonetheless undoubtedly find themselves overstretched. It is evident the number of cases waiting for a CE mark will largely outweigh the combined capacity of the available notified bodies and lead to delays. With a clear surplus of demand for regulatory certification services on the horizon, manufacturers must act quickly. If Class I manufacturers find their products have been up-classified, they should engage with a notified body right away before the latter find themselves at full capacity. Class I manufacturers too slow to join the regulatory waiting room may find their technical documentation has not been reviewed in time and may simply be left behind from the collective migration from MDD to EU MDR.

    Needless to say, notified bodies are unlikely to have any time to offer any additional support, given the already strenuous task of delivering the bare minimum of essential reviews on time. Hard pressed to find the kind of supplementary support manufacturers may wish for, it is probable some manufacturers may wisely seek out regulatory expertise elsewhere. This kind of auxiliary assistance would be particularly beneficial for Class I manufacturers that have never been required to previously seek notified body review. By engaging with other expert entities, manufacturers will be able to gain immediate access to regulatory assistance while waiting in line for a notified body. This will not only diminish the huge strain on these organizations, but also allow manufacturers to ensure their technical documentation is all in order before submission, thus enabling an efficient, hassle-free compliance process for themselves. Moreover, in light of the uncertainty around Brexit, manufacturers are strongly encouraged to engage an Authorized Representative within the EU 27 in order to prepare as best as possible for the upcoming deadline and any eventual complications or delays.

    At the forefront of a successful transition is the gathering of clinical data. Most Class I manufacturers are currently self-certified and rarely have the necessary quality management system or the clinical data to reach EU MDR compliance alone. Additional support would certainly be helpful in completing the new Quality Management System (QMS) requirements demanded of manufacturers under the EU MDR. Class I manufacturers will now require a formal QMS as per Article 10, paragraph 9, of the regulation, which is best served by implementing EN ISO 13485:2016. The QMS must include requirements for a formal Post-Market Surveillance report, which must be continuously and proactively updated with relevant clinical data, as cited in Article 85. All manufacturers will be subject to the post-market provisions of the MDR, including Post-Market Clinical Follow-Up, Post-Market Surveillance Update Reports, and vigilance reporting. These new regulatory requisites represent a considerable reform from the basic procedures required under the MDD.

    By complying now, manufacturers can use available post-market clinical data or perform a post-market study to submit as clinical evidence within the technical documentation itself. On the other hand, manufacturers who fail to fulfill these specifications within the set deadlines will not only have to remove their non-compliant products from the EU market, but to make matters worse, will also be unable to collect precisely the clinical evidence needed to complete the technical documentation required for compliance. Such a scenario would be highly undesirable and problematic for any business. As such, Class I manufacturers should not underestimate the time, preparatory work, and resources required to meet total EU MDR compliance within the set times, and should engage with a notified body as soon as possible (if required), while also considering other available options of independent regulatory expertise. Complacency and insufficient resource and time allowances could prove highly damaging for ill-prepared manufacturers.

    Class I manufacturers who wait too long to get in line to review their technical documentation are placing themselves in a precarious situation. As a matter of urgency, manufacturers should first read EU MDR Annex VIII in order to determine which classificatory amendments may impact the compliance requirements of their products. Next, manufacturers must immediately reach out to a notified body to achieve CE marking before waiting lines become too long and advisory capabilities are completely depleted. Finally, manufacturers are urged to seek out some supplementary expertise, to help ease the weight placed on the shoulders of notified bodies and to guarantee a smooth transition procedure for all. To successfully receive their required CE certifications by May 26, 2020, Class I manufacturers must prioritize EU MDR conformity and allow for enough time to gather the obligatory clinical data and have these reviewed by a notified body. With this deadline rapidly approaching, it is essential manufacturers recognize the overdemand for notified body input and quickly start piecing together their EU MDR technical documentation to submit for a speedy review. 


    Peter Rose is the managing director and practice leader for Maetrics’ operations in Europe. Having worked in the medical device industry for over 20 years, Rose has a wealth of experience and knowledge in quality systems and regulatory affairs. He is a lead auditor and a qualified microbiologist, and has been recognized for his extensive experience with sterilization. 
    Related Searches
    • assessment
    • first
    • body
    • medical device
    Suggested For You
    U.S. May Offer a Safe Harbor from the Impending MDR Storm U.S. May Offer a Safe Harbor from the Impending MDR Storm
    Globalization: Will Your 2019 Regulatory Strategy Help You Win in 2020? Globalization: Will Your 2019 Regulatory Strategy Help You Win in 2020?
    Trends, Opportunities, and Drivers in Early-Stage Life Sciences Investing Trends, Opportunities, and Drivers in Early-Stage Life Sciences Investing
    The Legacy of Apple Health The Legacy of Apple Health
    The Benefits of Software-Powered Electronics Manufacturing The Benefits of Software-Powered Electronics Manufacturing
    Inochi Care Wins at Medtech Innovator Pitch Event Inochi Care Wins at Medtech Innovator Pitch Event
    Mayday: How the Upcoming MDR Implementation Forecasts Disaster for Our Industry Mayday: How the Upcoming MDR Implementation Forecasts Disaster for Our Industry
    Messe Düsseldorf to Organize Medical Fair Brasil Messe Düsseldorf to Organize Medical Fair Brasil
    7th Annual Pediatric Device Innovation Symposium in Boston 7th Annual Pediatric Device Innovation Symposium in Boston
    New CEO at NeuroPace New CEO at NeuroPace
    Turning a Regulatory Headache into a Competitive Advantage Turning a Regulatory Headache into a Competitive Advantage
    Package Validations – A Look at Current and Future State Testing Package Validations – A Look at Current and Future State Testing
    Automation: The First Step to Industry 4.0 Automation: The First Step to Industry 4.0
    Toughened Epoxy Polysulfide Hybrid Offers Advanced Chemical Resistance Toughened Epoxy Polysulfide Hybrid Offers Advanced Chemical Resistance
    MedTech Innovator Selects 50 Best-in-Class Startups for 2019 Showcase and Accelerator MedTech Innovator Selects 50 Best-in-Class Startups for 2019 Showcase and Accelerator

    Related Columns

    • Diagnostics
      From Genome Sequencing to the World’s First Portable MRI

      From Genome Sequencing to the World’s First Portable MRI

      Dr. Jonathan Rothberg has risen about as high as a scientist can, save for the Nobel Prize.
      Sam Brusco, Associate Editor 11.04.19

    • Digital Health
      An Update on Digital Health

      An Update on Digital Health

      Sure, most are startups—but not all. There were some brilliant ideas presented at The MedTech Conference (AdvaMed’s annual meeting) on Sept. 23-25 in Boston and the Connected Health Conference, also in Boston, put on by Partners Health…
      Maria Shepherd, President and Founder, Medi-Vantage 11.04.19

    • ‘If You’re Reading This, You Need to Be at This Meeting’

      ‘If You’re Reading This, You Need to Be at This Meeting’

      The AAOS/FDA/Industry Townhall is taking place March 24, 2020, at the AAOS annual meeting in Orlando.
      Dawn A. Lissy, President & Founder, Empirical 11.04.19


    • Five Steps for Succeeding Globally in Medtech

      Five Steps for Succeeding Globally in Medtech

      World views can differ considerably, so it is important to understand, appreciate, and respect cultural realities and differences.
      Florence Joffroy-Black and Dave Sheppard, MedWorld Advisors 11.04.19

    • Software & IT
      Unlocking Market Doors with Real-World Evidence

      Unlocking Market Doors with Real-World Evidence

      Real-world evidence is becoming increasingly important for manufacturers to demonstrate value beyond efficacy and safety standards.
      Seth Goldenberg, Ph.D., Vice President, Vault Medical Device & Diagnostics, Veeva Systems 11.04.19

    • Contract Manufacturing
      Sales Tips for Contract Manufacturers of Finished Devices

      Sales Tips for Contract Manufacturers of Finished Devices

      Evolving trends in the supply chain may require companies to consider a strategy of selling devices of their own design.
      Tony Freeman, President, A.S. Freeman Advisors LLC 11.04.19


    • Impeachment, Executive Orders, and Must-Pass Congressional Legislation: A Fall Update

      Impeachment, Executive Orders, and Must-Pass Congressional Legislation: A Fall Update

      The final quarter of 2019 has begun, which means Congress and the Trump Administration are hard at work finalizing healthcare initiatives before year's end.
      Jeffrey J. Kimbell, David C. Rudloff and Caroline P. Tucker, Jeffrey J. Kimbell & Associates Inc. 11.04.19

    • R&D & Design
      Perfecting Drug Delivery Device Design

      Perfecting Drug Delivery Device Design

      Unlike medical products that just need to work, drug delivery devices must also consider intuitiveness, usability, and how it makes the user feel when operated.
      Bryce G. Rutter, Ph.D., Founder & CEO, Metaphase Design Group Inc. 11.04.19

    • Diagnostics
      Elizabeth Holmes: The Making of a Pop Culture Icon

      Elizabeth Holmes: The Making of a Pop Culture Icon

      Despite keeping a relatively low profile this year (not by choice), Elizabeth Holmes’ celebrity status has continued to grow.
      Michael Barbella, Managing Editor 10.08.19


    • A Look at Physician/Surgeon Salary and Employment Statistics

      A Look at Physician/Surgeon Salary and Employment Statistics

      No more call for physicians? Not really, but schedule predictability is in for physicians.
      Maria Shepherd, President and Founder, Medi-Vantage 10.08.19

    • Bridging Generation Gaps to Build Better Teams and Business

      Bridging Generation Gaps to Build Better Teams and Business

      I’ve learned the hard way that building teams of motivated, productive employees is equal parts science and art.
      Dawn A. Lissy, President & Founder, Empirical 10.08.19

    • Testing
      Managing Risks for Medical Devices:  A Guide to Understanding ISO 14971

      Managing Risks for Medical Devices: A Guide to Understanding ISO 14971

      The intent of ISO 14971 is to provide a general “bird’s-eye view” approach to designing and implementing a risk management plan for medical devices.
      Helin Räägel, Ph.D., Biocompatibility Expert, Nelson Labs 10.08.19

    • Testing
      Preparing for MDR: Test In-House or Outsource?

      Preparing for MDR: Test In-House or Outsource?

      As the EU MDR deadline draws near, manufacturers are under pressure to bring products into compliance and get submissions in front of regulators ASAP.
      Sandi Schaible, Senior Director, Analytical Chemistry and Regulatory Toxicology, WuXi Medical Device Testing 10.08.19

    • Think Chinese Tariffs Are the Only Industry Job Killers? Think Again

      Think Chinese Tariffs Are the Only Industry Job Killers? Think Again

      One of the latest concerns—arising from an old issue—is the medical device tax, which could return next year without legislative intervention before then.
      Florence Joffroy-Black and Dave Sheppard, MedWorld Advisors 10.08.19

    • Contract Manufacturing | Software & IT
      Five Ways Quality 4.0 Is Changing the Face of Medical Device Manufacturing

      Five Ways Quality 4.0 Is Changing the Face of Medical Device Manufacturing

      Industry 4.0 represents the dawn of the digital transformation that began with the third revolution, connecting the physical and natural worlds.
      Scott Reedy, Senior Director of Marketing, Arena Solutions 10.08.19


    Breaking News
    • FDA OKs World's First Single-Use Duodenoscope
    • Dr. Stephen Hahn Confirmed as New FDA Leader
    • FDA OKs First Test to Help Screen for Newborn Duchenne Muscular Dystrophy
    • MedStar Health and Cleveland Clinic Innovations Awarded Grant
    • 3M to Sell Drug Delivery Business for $650M
    View Breaking News >
    CURRENT ISSUE

    November/December 2019

    • Adding Fabrication Capabilities: Additive Manufacturing for Production Parts
    • Delivering the Goods: The Evolving World of Combination Products
    • Anxious Undertones: The 2019 Year in Review
    • View More >
    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Deerland Obtains Certification from Australia’s Therapeutic Goods Administration
    OptiMSM Shown to Improve Hair & Nail Appearance and Condition
    DCC Acquires Contract Manufacturer Ion Laboratories
    Coatings World

    Latest Breaking News From Coatings World

    Arkema: Bostik Acquires Danish Company LIP
    Axalta Adds New Epoxy Primer to Tufcote Liquid Industrial Coatings Portfolio
    Chromaflo Technologies Promotes Sergio Duenas to Country Manager of Mexico
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    FDA OKs World's First Single-Use Duodenoscope
    Dr. Stephen Hahn Confirmed as New FDA Leader
    FDA OKs First Test to Help Screen for Newborn Duchenne Muscular Dystrophy
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Sanofi Awarded $226M by US Gov't for Pandemic Influenza Preparedness
    Amgen Selects Location For R&D Facility
    Arctoris Opens Oxford R&D Facility
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Time Features 5 Best Beauty Inventions
    CES 2020 Preview - Innovation Award Honorees in Health & Wellness
    Prada & L’Oréal Sign Long-Term Licensing Deal
    Happi

    Latest Breaking News From Happi

    Cosmetic Assessments Revealed at CIR Panel
    T-Boz Launches CBD Line
    DRF and Flowerkist Develop CBD Range
    Ink World

    Latest Breaking News From Ink World

    Ripon Printers Adds Ricoh Pro C9210
    LogoJet Opens Bogota, Colombia Office
    Canon Solutions America Powers University of Notre Dame Athletics' Printing Capabilities
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    GSE products provide quality assurance for Pharmalabel
    Luminer promotes Heather Bookman to prepress manager
    Materials Exchange launches to solve excess inventory issue
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    DuPont to Acquire Osmosis Specialist
    Nice-Pak to Expand in Indiana
    Hospeco Launches Compact Fem Hy Dispenser
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    FDA OKs First Test to Help Screen for Newborn Duchenne Muscular Dystrophy
    Europe, North America Comprise More Than 80 Percent of Global Bone Marrow Transplantation Demand
    TriMed Closes Out FDA Warning Letter
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    3D Printing Materials Market to Grow at 23.9% CAGR Through 2025: GVR
    Kyocera, TactoTek Collaborate on Injection Molded Structural Electronics Solutions
    Toray Opens R&D Innovation Center for the Future

    Copyright © 2019 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.